2024-11-06 - Analysis Report
## Teladoc Health Inc (TDOC) Analysis:

**1. Performance Overview:**

Teladoc Health Inc (TDOC) is a telehealth company that provides virtual healthcare services. As of the latest data, TDOC has underperformed the S&P 500 (VOO) by a significant margin.  

* **TDOC Cumulative Return:** 52.18%
* **VOO Cumulative Return:** 132.58%
* **Performance Difference:** -80.4% (Relative I격도: 0.8)

This means TDOC's performance has been in the bottom 80% percentile relative to the S&P 500's performance over the historical period. Analyzing the Alpha and Beta: 

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015 | -5.5% | 51.0% | -4.7% | 1.0 |
| 2016 | -8.3% | 16.3% | -19.7% | 1.5 |
| 2017 | 111.2% | 19.7% | 92.6% | 1.7 |
| 2018 | 36.9% | 46.7% | 43.9% | 1.8 |
| 2019 | 73.8% | 26.3% | 45.1% | 2.0 |
| 2020 | 140.2% | 29.5% | 125.0% | 0.2 |
| 2021 | -54.2% | 55.8% | -83.0% | 1.4 |
| 2022 | -75.1% | 13.6% | -55.1% | 2.0 |
| 2023 | -4.6% | 18.2% | -29.4% | 2.3 |
| 2024 | -59.5% | 35.2% | -80.2% | 1.4 |

The table shows that TDOC's performance is highly volatile and has struggled to outperform the market consistently. It has a Beta greater than 1, indicating a higher risk than the market average.

**2. Recent Price Movement:**

* **Closing Price:** 9.15
* **5-Day Moving Average:** 9.02
* **20-Day Moving Average:** 9.15
* **60-Day Moving Average:** 8.32

The stock is currently trading near its 20-day moving average, suggesting short-term stability. The 5-day moving average is slightly below the current price, implying a potential upward trend in the short term. However, the 60-day moving average is significantly lower, indicating a longer-term downtrend.

**3. Technical Indicators:**

* **RSI:** 41.64
* **PPO:** -0.46
* **Delta_Previous_Relative_Divergence:** 0.16 (+)
* **Expected Return:** 0.0%

The RSI suggests the stock is in neutral territory. The PPO is slightly negative, indicating a potential bearish trend. The positive Delta_Previous_Relative_Divergence indicates a short-term upward trend in the stock's relative performance.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-31 | -0.19 | 0.64 B$ |
| 2024-08-01 | -4.92 | 0.64 B$ |
| 2024-04-26 | -0.49 | 0.65 B$ |
| 2023-10-27 | -0.35 | 0.66 B$ |
| 2024-10-31 | -0.35 | 0.66 B$ |

Teladoc's most recent earnings report showed an EPS of -$0.19 and revenue of $0.64 billion. While revenue remained consistent, earnings continue to decline. This suggests a challenge in profitability for the company, despite its consistent revenue stream. 

**5. Financial Information:**

1) **Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $0.64B | 71.94% |
| 2024-06-30 | $0.64B | 70.73% |
| 2024-03-31 | $0.65B | 69.89% |
| 2023-12-31 | $0.66B | 70.72% |
| 2023-09-30 | $0.66B | 71.83% |

The company has consistently maintained a high profit margin despite its recent decline in profitability. This indicates that Teladoc is still generating significant revenue from its core business.

2) **Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $1.51B | -2.21% |
| 2024-06-30 | $1.50B | -55.77% |
| 2024-03-31 | $2.29B | -3.58% |
| 2023-12-31 | $2.33B | -1.24% |
| 2023-09-30 | $2.29B | -2.49% |

The declining Return on Equity (ROE) is concerning, indicating that the company is not generating as much profit from its capital as it previously did.

**6. News and Recent Issues:**

**News:**

* **Earnings Release:** Teladoc recently released its earnings for the quarter ended September 30th, 2024. The results were below expectations, causing a drop in the stock price. 

**Market Outlook:**

* **Analyst Opinions:** Analysts are generally mixed on TDOC, with some seeing potential for growth in the telehealth market, while others are concerned about the company's profitability and its ability to compete in a crowded market. 

**Performance Highlights:**

* **Recent Market Volatility:** The telehealth industry has experienced significant volatility in recent years due to a range of factors including regulatory changes, competition from established healthcare providers, and the impact of the COVID-19 pandemic.

**7. Overall Analysis:**

Teladoc Health Inc is currently facing challenges in its performance, with declining profitability and consistent underperformance against the S&P 500. While the company maintains a strong revenue stream and high profit margins, its declining ROE and recent earnings miss raise concerns about its long-term sustainability.  The technical indicators suggest short-term stability but the long-term trend remains bearish. The news surrounding the company is mainly focused on its recent earnings release and the ongoing challenges in the telehealth industry. Considering all these factors, TDOC appears to be a high-risk investment with uncertain future prospects.

**8. Investment Recommendation:**

Based on the analysis, TDOC is not recommended as an investment at this time. While the company might have potential for growth in the future, the current challenges and uncertainty surrounding its profitability make it a high-risk investment. Investors should proceed with caution and conduct thorough research before considering any investment in TDOC. 

**Disclaimer:** This information is for educational purposes only and should not be considered as financial advice. It is essential to conduct thorough research and consult with a financial advisor before making any investment decisions.
